Patient perspectives on nipple-areola complex micropigmentation during the COVID-19 pandemic.

Abstract

Micropigmentation is a well-recognised option for nipple-areola complex reconstruction, as part of the breast reconstruction pathway for patients following mastectomy. As a part of delayed breast reconstruction, this treatment was put on hold during the COVID-19 pandemic. To assess the views of patients regarding micropigmentation in response to the COVID-19 pandemic, and whether their attitudes to seeking out this part of the reconstructive journey had been altered. A questionnaire undertaken with 53 patients between August & September 2020 attending the Micropigmentation clinic. 81.1% of patients reported COVID-19 had not impacted their decision, with a similar proportion happy to proceed with the treatment at the time of questioning. The results highlight the importance of nipple-areola complex to our patients' reconstructive journey.